Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old
Abstract
Twenty-six children (aged 18-36 months) previously hospitalized for respiratory syncytial virus (RSV) infection were randomized to receive 50 micrograms of an RSV subunit vaccine composed primarily of F glycoprotein or saline placebo by intramuscular injection. Serum was obtained at entry and at 1 a …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
Child
Infant
preschool
Clinical Trial
Randomized Controlled Trial
Antibodies
r c welliver
viral / analysis*
respiratory syncytial viruses / immunology*
viral / blood
immunoglobulin g / blood
hn protein*
viral envelope proteins
immunoglobulin a
secretory / analysis
viral proteins / immunology*
viral vaccines / adverse effects
viral vaccines / immunology*
d a tristram
p paradiso
pmid:8418166
doi:10.1093/infdis/167.1.191
immunoglobulin e / analysis
Access
Citation
ID:
119778
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
119778
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet